English

NORDIC NANOVECTOR ASA – MANDATORY NOTIFICATION OF TRADE

Report this content

 

Jon Frode Vaksvik, a related party to Tone Kvåle CFO in Nordic Nanovector ASA (the "Company"), has on 24 August 2016 purchased 5,000 shares in the Company at an average share price of NOK 28,2684 per share. Following the transaction, Tone Kvåle and related parties will together hold 174,854 shares in the Company and Tone Kvåle will hold 210,000 options in the Company.

This information is subject to duty of disclosure pursuant to section 4-2 of the Norwegian Securities Trading Act.

 

 

Tags:

Cancer Therapy non-hodgkins lymphoma Betalutin Nordic Nanovector Radioimmunotherapy Roy Hartvig Larsen anticancer therapeutics

Subscribe